When Treatment Can't Wait: Medical Timing, Patient Barriers, and the Clinical Case for Round-the-Clock Ivermectin Access
For certain parasitic conditions, delays in initiating ivermectin therapy can meaningfully affect patient outcomes—yet structural barriers continue to limit timely access for many Americans. This article examines the clinical scenarios where timing matters most, the insurance and pharmacy gaps that complicate fulfillment, and what the evidence tells us about the real-world consequences of delayed treatment.